RecruitingNot Applicable

An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury

United States10 participantsStarted 2026-07-14

Plain-language summary

The early prospective study of Traq™ (an investigational binocular ophthalmic neurodiagnostic device) will measure binocular ocular functions (bilateral foveal fixation, foveal binocularity, and fovea-tracked saccadic latency) in normal subjects and those with history of mild-to moderate traumatic brain injury (mTBI).

Who can participate

Age range

12 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Age 12 years or older at the time of enrollment.
. Able to understand and sign an informed consent form (or with parent/guardian for subjects less than 18 years of age).
. Willing and able to complete all required study visits and test assessments.
. Subjects with no history of traumatic brain injury (normal arm).
. Subjects with a history of mild to moderate traumatic brain injury (mTBI) within the last six months, (post-TBI arm).

Exclusion criteria

. Concurrent participation in another drug or device clinical investigation.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Device Metrics

Timeframe: Four individual scans through study completion: Day 0, Day 30, Day 60, Day 90.

Device Metrics

Timeframe: Four individual scans through study completion: Day 0, Day 30, Day 60, Day 90.

Foveal fixation

Timeframe: Four individual scans through study completion: Day 0, Day 30, Day 60, Day 90.

Device outputs

Timeframe: Four individual scans through study completion: Day 0, Day 30, Day 60, Day 90.

Trial details

NCT IDNCT07742878

SponsorRebiscan, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-10

Contact for this trial

Justin Shaka

857-600-0982 jgshaka@rebiscan.com

View on ClinicalTrials.gov More Mild Traumatic Brain Injury, Concussion trials

Plain-language summary

Who can participate

Age range

12 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Age 12 years or older at the time of enrollment.
. Able to understand and sign an informed consent form (or with parent/guardian for subjects less than 18 years of age).
. Willing and able to complete all required study visits and test assessments.
. Subjects with no history of traumatic brain injury (normal arm).
. Subjects with a history of mild to moderate traumatic brain injury (mTBI) within the last six months, (post-TBI arm).

Exclusion criteria

. Concurrent participation in another drug or device clinical investigation.

What they're measuring

Device Metrics

Timeframe: Four individual scans through study completion: Day 0, Day 30, Day 60, Day 90.

Device Metrics

Timeframe: Four individual scans through study completion: Day 0, Day 30, Day 60, Day 90.

Foveal fixation

Timeframe: Four individual scans through study completion: Day 0, Day 30, Day 60, Day 90.

Device outputs

Timeframe: Four individual scans through study completion: Day 0, Day 30, Day 60, Day 90.